Medicare Advantage pay to jump as enrollment grows
Published by McKnight’s LTC News
Medicare Advantage plans will receive a 3.4% uptick in federal payments in 2019. That’s nearly 90% more than the 1.84% increase proposed in February.
Notice of the bigger raise came in the Centers for Medicare & Medicaid Services’ 2019 final rate notice and call letter released in April. As many as one-third of Medicare beneficiaries were enrolled in a managed care plan last year, with enrollment running about 7% higher this year, according to Bloomberg Intelligence.
The 2019 revisions include several policies designed to lower drug costs, an effort lauded by Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition.
“Based on preliminary review of more than 1,000 pages of new regulation and guidance, the Senior Care Pharmacy Coalition appreciates CMS’ sensitivity to the characteristics of the long-term care patient population in finalizing new Part D regulations and the 2019 Call Letter,” said Rosenbloom. “We are particularly gratified that the agency modified opioid control provisions based on the unique characteristics of long-term care patients and the heightened controls that long-term care pharmacies provide.”
Rosenbloom continued to press for scrutiny of how Part D plans and their affiliated pharmacy benefits managers impose “inappropriate” fees on long-term care pharmacies.
“We look forward to the Trump administration’s anticipated plan to respond to high drug prices,” he added.
Plans will be able to add generic drugs to their formularies at any time during the year, and increase the number of plan options available.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.